Notice Educational use only. CompoundProfile publishes evidence summaries. This is not medical advice and does not constitute a recommendation to use any compound.
CHS-AI Agent CompoundPurity.ca
Peptides · 54 Compounds
5-Amino-1MQ
50 mg
AOD-9604
AURA Blend
15 mg
BPC-157
5 mg
BPC-157 + TB-500 Blend
10 mg
CJC-1295 + Ipamorelin
7 mg
CJC-1295 No DAC
2 mg
CJC-1295 With DAC
2 mg
DIHEXA
--
DSIP
5 mg
Epithalon
10 mg
FOLLISTATIN-344
--
FOXO4-DRI
--
GHK-Cu
50 mg
GHRP-2
5 mg
GHRP-6
5 mg
GLP-1 / Semaglutide
1 mg
GLP-2 / Teduglutide
Glutathione
200 mg
GONADORELIN
--
HEXARELIN
100–200 mcg
IGF-LR3
Ipamorelin
5 mg
Kisspeptin
Kisspeptin-10
KLOW Blend
10 mg
KPV
LIRAGLUTIDE
--
Melanotan I
10 mg
Melanotan II
10 mg
Metabolic Blend
10 mg
MK-677
--
MOTS-C
NAD+
Pancragen
PEG-MGF
--
Pinealon
PT-141
10 mg
Regeno Blend
Retatrutide
Selank
Selank + Semax Blend
10 mg
Semax
Sermorelin
SS-31 (Elamipretide)
TB-500
Tesamorelin
Tesamorelin + Ipamorelin
Thymagen
Thymosin Alpha-1
TIRZEPATIDE
--
Vesugen
Vilon
VIP
--
Agent Active  ·  Scoring Infrastructure

AI Agent
Health Score
Methodology

How the AI Agent Compound Health Score (AI-CHS) synthesises public sentiment, evidence signals, and source-weighted discourse data across peptide research compounds and the hard limits of what an AI-derived score can and cannot tell you.

last update  2026-08-04 · 09:14 UTC | run_id  chs_20260804_full_v4 | n=44 · status=OK · conf=HIGH | cutoff  2025-05

Agent Architecture

The AI Agent Compound Health Score (AI-CHS) (CHS-AI) is a multi-step inference pipeline that runs CHS-AI Agent against a structured query template for each compound, producing two independent scores: an Evidence Score derived from published research quality signals, and a Sentiment Score derived from public discourse analysis across four weighted source channels.

Each pipeline run is scoped to a single compound and runs in parallel across all 44 profiles. Output is validated against a confidence threshold; runs that fail to meet the minimum token window are flagged and re-queued.

DATA INGESTION LAYER COMMUNITY FORUMS r/Peptides · r/Nootropics Longecity · PeptideForum 40% PODCASTS & VIDEO Huberman · Attia · Rogan Greenfield · FoundMyFit 25% BIOHACKER BLOGS Self-experimenters Protocol write-ups 20% MEDICAL PRESS STAT · Undark · BBC NYT Health · Forbes 15% DISCOURSE SAMPLING ENGINE COMPOUND QUERY INIT compound_id + aliases + CAS → system_prompt injection → context_window sizing volume_tier: HIGH | MODERATE | LOW → token_budget: 8192 | 4096 | 2048 PARALLEL EXECUTION 44 workers × 1 compound async · batched · queued SENTIMENT CLASSIFICATION POSITIVE Favourable exp · endorsement Desired outcomes confirmed NEUTRAL Dosing Qs · mechanism inquiry → excluded from ratio calc SKEPTICAL Qualified endorsement + caveat Inconsistent result reports NEGATIVE Adverse reports · reg. concern Active debunking · fraud flag SOURCE WEIGHT MATRIX forums 40% podcasts 25% blogs 20% press 15% VOLUME NORMALISATION mentions < 100 → LOW_VOL flag conf_interval adjusted ±σ SCORE COMPUTATION & VALIDATION sentiment_score = Σ(positive_units × source_weight) / Σ(classified_units × source_weight) evidence_score = research_quality_index(pub_count, trial_phase, recency, citation_depth) if conf < threshold → requeue(compound_id) · max_retries=3 SCORE EMISSION EVIDENCE SCORE 36% pub_quality_signals · trial_phase citation_depth · recency_decay SENTIMENT SCORE 82% weighted_positive_ratio vol_normalised · conf=HIGH ICPS EFFECTIVE SCORE 1.8/5 emit → profile_page · version_tag run_id=chs_20260804_0001 EXAMPLE · BPC-157 · run_id chs_20260804_0001
01
Compound Query Init
Compound name, aliases, CAS, and category are injected into the system prompt. Context window is sized to the known discussion volume tier.
02
Discourse Sampling
The model synthesises representative discussion from training data: forums, podcasts, press, and biohacker content. Output is structured JSON with source-type labels.
03
Sentiment Classification
Each discourse unit is classified: Positive / Neutral / Skeptical / Negative. Neutral units are excluded from the ratio calculation.
04
Source Weighting
Source-type weights are applied (40 / 25 / 20 / 15). Volume normalisation adjusts confidence interval. Low-volume compounds are flagged.
05
Score Emission
Final weighted scores are emitted with confidence flags, version tag, run timestamp, and approximate mention volume for each source channel.
chs-agent · run_log · compound_0001_bpc157
[2026-08-04 09:14:02 UTC] INIT compound=BPC-157 aliases=["PL 14736","Bepecin","Pentadecapeptide"] category=performance_recovery
[2026-08-04 09:14:03 UTC] QUERY model=chs-ai-agent-v4.6 window=8192 context_tokens=1847
[2026-08-04 09:14:05 UTC] DISC sources_sampled=4 discourse_units=312 volume_tier=HIGH
[2026-08-04 09:14:06 UTC] CLASS positive=231 neutral=54 skeptical=19 negative=8
[2026-08-04 09:14:06 UTC] WEIGHT forums=81% podcasts=91% blogs=88% press=28%
[2026-08-04 09:14:07 UTC] SCORE evidence=36% sentiment=82% icps=1.8 confidence=HIGH mentions=2800+
[2026-08-04 09:14:07 UTC] EMIT status=OK version=chs-ai-agent-v4.6·may2025 run_id=chs_20260804_0001

Source channels and weights

The agent draws on four source channel types from the CHS-AI Agent model's training corpus. Weights are calibrated to reflect genuine user experience signal rather than promotional volume — community forums carry the highest weight because they represent the largest pool of authentic first-person discussion.

ChannelSources IncludedWeightSignal Type
Community Forums r/Peptides, r/Nootropics, r/Biohacking, r/PeptideScience, Longecity, PeptideForum.com 40% First-person user experience
Podcasts & Video Huberman Lab, The Joe Rogan Experience, The Peter Attia Drive, FoundMyFitness, Ben Greenfield Life, SuperHuman Radio 25% Expert and influencer commentary
Biohacker Blogs Independent self-experimenters, longevity newsletters, protocol write-ups, personal blogs 20% Documented protocol outcomes
Medical & Mainstream Press STAT News, Undark, BBC Health, New York Times Health, peer-reviewed lay summaries, WWD, Forbes Health 15% Institutional and journalistic coverage

Why medical press receives only 15%: Institutional skepticism of gray-market peptides is well-founded but already reflected in the ICPS Evidence Score. Including it at full weight in the sentiment score would double-count the same signal. Medical press sentiment is a different question from clinical evidence quality.

Sentiment classification

Each discourse unit sampled by the agent is assigned to one of four classifications. Neutral units are excluded from the final ratio; the score reflects: of all mentions with a clear sentiment signal, what proportion is positive?

▲ Positive
Favourable personal experience, endorsement by named figures, positive clinical commentary, enthusiasm about mechanism of action, or reports of desired outcomes matching the compound's proposed indication.
◆ Neutral
Factual discussion without clear sentiment polarity — dosing questions, mechanism inquiries, protocol comparisons, sourcing questions. Excluded from ratio calculation.
◈ Skeptical
Qualified endorsement with noted caveats, inconsistent result reports, questions about bioavailability, or uncertainty about whether a specific outcome was compound-attributable.
▼ Negative
Adverse experience reports, regulatory concern, fraud or counterfeiting warnings, strong clinical skepticism, or active debunking by credentialed critics.
Score interpretation Positive ratio of sentiment-classified discourse
0–39%
Negative
40–59%
Poor
60–74%
Mixed
75–89%
Positive
90–100%
Highly Regarded

All 44 compounds — current scores

Evidence %, Sentiment %, and ICPS Effective Score for all compounds in the CompoundProfile library. Click any column header to sort. Filter by category using the buttons below.

last update  August 4, 2026
44 compounds
Compound Category Evidence % Sentiment % ICPS Score Status

What this score cannot do

The Sentiment Score has meaningful constraints that must be understood before it informs any decision. These are not caveats added for legal protection — they are genuine epistemic limits of the method.

Training data cutoff May 2025. Sentiment shifts after that date — regulatory events, new adverse reports, updated clinical findings, viral coverage — are not reflected. The Run Update button simulates a re-query but does not change the underlying model data.

Promotional content may have entered training data and can inflate positive sentiment for commercially marketed compounds. The source weighting system partially mitigates this, but it cannot eliminate it entirely. Compounds with very active commercial marketing should be read with this in mind.

Sentiment is not efficacy. A compound can score 85% sentiment with 22% evidence — that gap is meaningful data, not noise. The score specifically measures what people say and believe, not what controlled research has established. Always read the ICPS Evidence Score alongside the Sentiment Score.

The two-score model exists precisely because these signals diverge. Where they align (high evidence, high sentiment) you get compounds like GLP-1/Semaglutide. Where they diverge most (low evidence, high sentiment) you get the clearest cases for user caution — such as IGF-LR3, MOTS-C, or 5-Amino-1MQ.

Score versioning

Each score run is tagged with the CHS-AI Agent model version, training data cutoff, and run timestamp. As new model versions with updated training data become available, scores will be recalculated and the version log updated on each profile page.

FieldCurrent Value
Modelchs-ai-agent-v4.6
Training Data CutoffMay 2025
Last Full RunAugust 4, 2026 · 09:14 UTC
Compounds Scored44 of 44
Failed Runs0
Low-Volume Flags8 compounds (under 100 tracked mentions)
Run IDchs_20260804_full_v4